United States · Series B startup

Who invested in Cardinal Analytx

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$28Mraised across 2 rounds since 2017, from 2 sources

$6.1MSeries A$22MSeries B
Latest round
Series B, $22MMay 2019
Led by
John Doerr
Step-upi
3.6×
Investors
6 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182019
$6.1MSeries A$22MSeries B
First round
Series A, $6.1M
Sept 2017
Biggest round
$22M
Series B · May 2019
Between rounds
20 months
from the last two
Cardinal AnalytxBiotech/health1 / 12Their pitch deckCardinal Analytx's pitch deck, 12 slidesEach slide read for what it argues, against the decks that raised at the same stage.

The rounds

  1. May 2019
    Series B$22M4 new

    Reported by FinSMEsSEC filing: $21M sold, first sale Mar 2019

  2. Sept 2017
    Series A$6.1M2 new

    Reported by FinSMEsSEC filing: $2.8M sold, first sale May 2017

Founders and team

From the SEC filings it signed: 2 on the team.

  • Linda T. HandExecutive Officer, Directori
  • Niall T. O'CathasaighExecutive Officeri

On the board, as filediElizabeth T. SpauldingKent T. MarquardtMark T. SmithThomas T. McKinley

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2017Series B2019John DoerrLStanford-StartXPremera Blue CrossBlue Shield CaliforniaCardinal Partners/ Premera Blue CrossGuideWell Mutual Holding

Everyone who backed them

John DoerrVC firm1round, led 1
Stanford-StartXInvestment firm1round
Premera Blue CrossCorporate VC1round
Blue Shield Californiano record of our own yet1round
Cardinal Partners/ Premera Blue Crossno record of our own yet1round
GuideWell Mutual Holdingno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cardinal Analytx

Who invested in Cardinal Analytx?

Cardinal Analytx's investors include John Doerr, Stanford-StartX, Premera Blue Cross, Blue Shield California and Cardinal Partners/ Premera Blue Cross, and 1 more on record. John Doerr led its latest round.

How much has Cardinal Analytx raised?

Cardinal Analytx has raised $28M across 2 rounds since 2017.

When did Cardinal Analytx last raise?

Cardinal Analytx's most recent round was a Series B of $22M in May 2019, led by John Doerr.

What was Cardinal Analytx's biggest round?

Its most recent round, $22M in May 2019, is also its largest on record.

Who backed Cardinal Analytx first?

Cardinal Analytx's first round on record, in Sept 2017, was backed by Stanford-StartX and Cardinal Partners/ Premera Blue Cross.

What stage is Cardinal Analytx at?

Cardinal Analytx's latest named round is a Series B, in May 2019.

Where is Cardinal Analytx based?

Cardinal Analytx is based in the United States.

Who led Cardinal Analytx's rounds?

John Doerr led the Series B in 2019.

Companies like Cardinal Analytx

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.